AMR is one of the biggest healthcare – and humanitarian – challenges we collectively face, contributing to at least 5 million deaths every year. In order to meet this challenge, BSAC has launched GASPH, a dedicated online space designed to bring organisations together to support appropriate antibiotic use and reduce antimicrobial resistance.

The BSAC sponsored, sell-out 2018 Fringe musical The Mould That Changed the World is back, with a return to the Edinburgh Festival Fringe and a visit to Glasgow in August '22. What’s more, they’re looking for a local chorus of scientists and healthcare professionals recruited in each city to join the professional cast…

The audited accounts and trustees report for the period ending 30 September 2021, which are submitted to the AGM, are available to view.

The All-Party Parliamentary Groups on Antibiotics, and Water, Sanitation and Hygiene, are staging a joint inquiry into the links between antibiotic resistance and lack of access to clean water, hygiene and sanitation facilities in healthcare settings across the least developed countries of the world.

BSAC welcomes news that two ‘last line of defence’ antibiotics - cefiderocol & ceftazidime with avibactam - will soon be available on the NHS as part of a new de-linkage scheme, a subscription-style payment model designed to incentivise investment in bringing new antibiotics through to clinical use.

In 2015 the World Health Assembly endorsed the Global Action Plan on antimicrobial resistance (AMR) calling on countries to develop and implement national action plans on AMR. Last week, WHO published an implementation handbook, offering guidance for the human health sector.

BSAC has joined the Infection Management Coalition (IMC), which brings together industry and charity leaders to help transform the way infection is detected, monitored, prevented, and managed, underpinned by the establishment of a global network of hospital-based, community-based and mobile laboratories to track the spread of antimicrobial resistance (AMR).

The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce a new partnership with Pfizer, focussing on the development of centres of excellence for Antimicrobial Stewardship (AMS) practice, with the goal of reducing inequities in access to AMS programmes and improving patient outcomes.